Press Release

Aura Biosciences to Present at the Jefferies 2019 Global Healthcare Conference

CAMBRIDGE, MA – May 28, 2019 – Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that Elisabet de los Pinos, Ph.D., Chief Executive Officer of Aura, will present a company overview at the Jefferies 2019 Global Healthcare Conference on Tuesday, June 4, 2019, at 2:00 p.m. Eastern Time in New York, NY.

About Aura Biosciences 

Aura Biosciences is developing a new class of therapies to selectively target and destroy cancer cells. Its lead program, AU-011 in primary choroidal melanoma, is being developed under a CRADA with the National Cancer Institute (NCI), part of the National Institutes of Health. For more information, visit 



David Rosen

Argot Partners

212.600.1902 | 


Joseph Rayne

Argot Partners

617.340.6075 |